CA Stock MarketDetailed Quotes

LABS MediPharm Labs Corp

Watchlist
  • 0.075
  • 0.0000.00%
15min DelayMarket Closed Jun 28 16:00 ET
30.36MMarket Cap-1875P/E (TTM)

MediPharm Labs Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
49.98%-1.53M
23.21%-12.34M
977.38%1.47M
-11.95%-3.23M
-1.59%-7.53M
45.54%-3.05M
-21.62%-16.07M
95.85%-168K
-1,088.07%-2.89M
-151.25%-7.41M
Net income from continuing operations
-16.94%-3.61M
56.37%-13.08M
47.14%-2.97M
45.44%-4.33M
69.92%-2.7M
58.59%-3.09M
45.29%-29.98M
74.23%-5.61M
-7.82%-7.93M
23.92%-8.99M
Operating gains losses
-6,480.00%-319K
-70.47%269K
-100.91%-10K
103.16%38K
-82.28%236K
101.58%5K
131.31%911K
540.56%1.1M
-1,680.26%-1.2M
357.73%1.33M
Depreciation and amortization
61.22%790K
-12.40%2.52M
32.78%717K
-18.17%617K
-8.83%692K
-40.17%490K
-49.01%2.87M
-77.34%540K
-15.66%754K
-48.72%759K
Asset impairment expenditure
--234K
27.76%1.75M
138.52%433K
-84.58%304K
--1.01M
--0
-89.40%1.37M
-116.87%-1.12M
289.72%1.97M
----
Remuneration paid in stock
101.49%23K
-1,534.33%-1.92M
129.81%48K
-86.44%40K
---464K
---1.55M
-98.03%134K
-102.61%-161K
--295K
--0
Remuneration paid in stock
19.81%895K
-29.42%2.03M
-77.99%306K
139.75%386K
1.38%588K
0.81%747K
19.57%2.87M
127.50%1.39M
-62.99%161K
21.85%580K
Other non cashItems
73.06%-66K
-1,420.70%-7.35M
-835.29%-2.23M
1,018.10%1.07M
-7,142.68%-5.94M
-421.28%-245K
-104.70%-483K
4.03%-238K
-134.94%-116K
-115.62%-82K
Change In working capital
-9.90%528K
-44.70%3.45M
31.34%5.17M
-142.64%-1.36M
37.98%-952K
-11.08%586K
-1.83%6.24M
65.49%3.94M
-27.41%3.18M
-1,548.11%-1.54M
-Change in receivables
-2,700.00%-616K
77.74%6.42M
318.87%5.77M
-314.95%-230K
1,204.35%900K
-101.07%-22K
-64.55%3.61M
-79.71%1.38M
-97.14%107K
103.11%69K
-Change in inventory
-106.68%-80K
3,123.30%3.11M
88.96%2.23M
-122.78%-416K
104.83%106K
231.50%1.2M
-104.14%-103K
18.75%1.18M
247.50%1.83M
-146.28%-2.2M
-Change in payables and accrued expense
336.68%1.88M
-446.48%-5.17M
-269.80%-1.27M
-439.27%-1.2M
-535.70%-1.9M
-1,668.89%-796K
118.39%1.49M
119.99%745K
111.83%354K
-62.93%437K
-Change in other current assets
59.00%159K
-160.89%-1.07M
-291.93%-1.38M
-30.61%807K
-54.15%-595K
-61.24%100K
152.01%1.75M
3.30%719K
--1.16M
---386K
-Change in other current liabilities
----
129.13%150K
-119.28%-182K
-15.81%-315K
----
----
-147.12%-515K
-126.95%-83K
-282.55%-272K
-21.02%541K
-Change in other working capital
-872.64%-819K
----
----
----
----
--106K
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
49.98%-1.53M
23.21%-12.34M
977.38%1.47M
-11.95%-3.23M
-1.59%-7.53M
45.54%-3.05M
-21.62%-16.07M
95.85%-168K
-1,088.07%-2.89M
-151.25%-7.41M
Investing cash flow
Cash flow from continuing investing activities
2,200.00%525K
33.23%6.87M
-24.49%4.31M
619.94%1.64M
1,187.36%946K
82.64%-25K
14,637.14%5.16M
1,937.50%5.71M
-834.88%-316K
34.09%-87K
Capital expenditure reported
16.00%-21K
45.42%-471K
61.49%-119K
17.72%-260K
28.72%-67K
82.64%-25K
-10.22%-863K
-50.00%-309K
-174.78%-316K
48.91%-94K
Net PPE purchase and sale
--326K
--178K
-24,542.86%-1.73M
--1.9M
--0
--0
--0
66.67%-7K
--0
----
Net business purchase and sale
----
-12.50%5.26M
-29.35%4.25M
--0
----
----
--6.01M
--6.01M
--0
----
Net other investing changes
--220K
27,085.71%1.9M
----
----
----
----
-98.62%7K
----
----
----
Cash from discontinued investing activities
Investing cash flow
2,200.00%525K
33.23%6.87M
-24.49%4.31M
619.94%1.64M
1,187.36%946K
82.64%-25K
14,637.14%5.16M
1,937.50%5.71M
-834.88%-316K
34.09%-87K
Financing cash flow
Cash flow from continuing financing activities
92.82%-66K
-146.23%-368K
39.60%-241K
-109.09%-299K
-19.30%1.09M
-6,464.29%-919K
-97.14%796K
-40,000.00%-399K
76.17%-143K
3,855.56%1.35M
Net issuance payments of debt
76.91%-269K
-340.20%-944K
27.32%-391K
-40.07%-388K
-21.26%1M
-1,779.03%-1.17M
113.27%393K
-564.20%-538K
-241.98%-277K
1,793.33%1.27M
Cash dividends paid
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Interest paid (cash flow from financing activities)
-425.00%-21K
-915.38%-264K
-196.15%-77K
-4,350.00%-85K
-4,800.00%-98K
---4K
-116.67%-26K
---26K
--2K
---2K
Net other financing activities
-10.40%224K
95.80%840K
37.58%227K
31.82%174K
125.00%189K
420.83%250K
408.63%429K
75.53%165K
140.12%132K
115.38%84K
Cash from discontinued financing activities
Financing cash flow
92.82%-66K
-146.23%-368K
39.60%-241K
-109.09%-299K
-19.30%1.09M
-6,464.29%-919K
-97.14%796K
-40,000.00%-399K
76.17%-143K
3,855.56%1.35M
Net cash flow
Beginning cash position
-25.53%17.98M
-29.21%24.15M
-33.43%12.95M
-32.97%14.74M
-28.73%20.15M
-29.21%24.15M
71.30%34.11M
-48.75%19.45M
-43.25%21.99M
-32.88%28.27M
Current changes in cash
73.29%-1.07M
42.31%-5.84M
7.84%5.54M
43.57%-1.89M
10.64%-5.49M
30.64%-4M
-169.16%-10.12M
236.50%5.14M
-318.25%-3.35M
-97.15%-6.15M
Effect of exchange rate changes
--12K
-319.33%-329K
-14.09%-510K
-88.12%96K
163.43%85K
--0
134.97%150K
-432.14%-447K
11,442.86%808K
47.45%-134K
End cash Position
-16.00%16.93M
-25.53%17.98M
-25.53%17.98M
-33.43%12.95M
-32.97%14.74M
-28.73%20.15M
-29.21%24.15M
-29.21%24.15M
-48.75%19.45M
-43.25%21.99M
Free cash from
49.71%-1.55M
24.34%-12.81M
384.07%1.36M
-9.02%-3.49M
-1.21%-7.6M
46.47%-3.08M
-20.98%-16.93M
88.78%-477K
-794.69%-3.2M
-139.50%-7.51M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 49.98%-1.53M23.21%-12.34M977.38%1.47M-11.95%-3.23M-1.59%-7.53M45.54%-3.05M-21.62%-16.07M95.85%-168K-1,088.07%-2.89M-151.25%-7.41M
Net income from continuing operations -16.94%-3.61M56.37%-13.08M47.14%-2.97M45.44%-4.33M69.92%-2.7M58.59%-3.09M45.29%-29.98M74.23%-5.61M-7.82%-7.93M23.92%-8.99M
Operating gains losses -6,480.00%-319K-70.47%269K-100.91%-10K103.16%38K-82.28%236K101.58%5K131.31%911K540.56%1.1M-1,680.26%-1.2M357.73%1.33M
Depreciation and amortization 61.22%790K-12.40%2.52M32.78%717K-18.17%617K-8.83%692K-40.17%490K-49.01%2.87M-77.34%540K-15.66%754K-48.72%759K
Asset impairment expenditure --234K27.76%1.75M138.52%433K-84.58%304K--1.01M--0-89.40%1.37M-116.87%-1.12M289.72%1.97M----
Remuneration paid in stock 101.49%23K-1,534.33%-1.92M129.81%48K-86.44%40K---464K---1.55M-98.03%134K-102.61%-161K--295K--0
Remuneration paid in stock 19.81%895K-29.42%2.03M-77.99%306K139.75%386K1.38%588K0.81%747K19.57%2.87M127.50%1.39M-62.99%161K21.85%580K
Other non cashItems 73.06%-66K-1,420.70%-7.35M-835.29%-2.23M1,018.10%1.07M-7,142.68%-5.94M-421.28%-245K-104.70%-483K4.03%-238K-134.94%-116K-115.62%-82K
Change In working capital -9.90%528K-44.70%3.45M31.34%5.17M-142.64%-1.36M37.98%-952K-11.08%586K-1.83%6.24M65.49%3.94M-27.41%3.18M-1,548.11%-1.54M
-Change in receivables -2,700.00%-616K77.74%6.42M318.87%5.77M-314.95%-230K1,204.35%900K-101.07%-22K-64.55%3.61M-79.71%1.38M-97.14%107K103.11%69K
-Change in inventory -106.68%-80K3,123.30%3.11M88.96%2.23M-122.78%-416K104.83%106K231.50%1.2M-104.14%-103K18.75%1.18M247.50%1.83M-146.28%-2.2M
-Change in payables and accrued expense 336.68%1.88M-446.48%-5.17M-269.80%-1.27M-439.27%-1.2M-535.70%-1.9M-1,668.89%-796K118.39%1.49M119.99%745K111.83%354K-62.93%437K
-Change in other current assets 59.00%159K-160.89%-1.07M-291.93%-1.38M-30.61%807K-54.15%-595K-61.24%100K152.01%1.75M3.30%719K--1.16M---386K
-Change in other current liabilities ----129.13%150K-119.28%-182K-15.81%-315K---------147.12%-515K-126.95%-83K-282.55%-272K-21.02%541K
-Change in other working capital -872.64%-819K------------------106K----------------
Cash from discontinued investing activities
Operating cash flow 49.98%-1.53M23.21%-12.34M977.38%1.47M-11.95%-3.23M-1.59%-7.53M45.54%-3.05M-21.62%-16.07M95.85%-168K-1,088.07%-2.89M-151.25%-7.41M
Investing cash flow
Cash flow from continuing investing activities 2,200.00%525K33.23%6.87M-24.49%4.31M619.94%1.64M1,187.36%946K82.64%-25K14,637.14%5.16M1,937.50%5.71M-834.88%-316K34.09%-87K
Capital expenditure reported 16.00%-21K45.42%-471K61.49%-119K17.72%-260K28.72%-67K82.64%-25K-10.22%-863K-50.00%-309K-174.78%-316K48.91%-94K
Net PPE purchase and sale --326K--178K-24,542.86%-1.73M--1.9M--0--0--066.67%-7K--0----
Net business purchase and sale -----12.50%5.26M-29.35%4.25M--0----------6.01M--6.01M--0----
Net other investing changes --220K27,085.71%1.9M-----------------98.62%7K------------
Cash from discontinued investing activities
Investing cash flow 2,200.00%525K33.23%6.87M-24.49%4.31M619.94%1.64M1,187.36%946K82.64%-25K14,637.14%5.16M1,937.50%5.71M-834.88%-316K34.09%-87K
Financing cash flow
Cash flow from continuing financing activities 92.82%-66K-146.23%-368K39.60%-241K-109.09%-299K-19.30%1.09M-6,464.29%-919K-97.14%796K-40,000.00%-399K76.17%-143K3,855.56%1.35M
Net issuance payments of debt 76.91%-269K-340.20%-944K27.32%-391K-40.07%-388K-21.26%1M-1,779.03%-1.17M113.27%393K-564.20%-538K-241.98%-277K1,793.33%1.27M
Cash dividends paid --0--0--0--0--0--0--0--0--0--0
Interest paid (cash flow from financing activities) -425.00%-21K-915.38%-264K-196.15%-77K-4,350.00%-85K-4,800.00%-98K---4K-116.67%-26K---26K--2K---2K
Net other financing activities -10.40%224K95.80%840K37.58%227K31.82%174K125.00%189K420.83%250K408.63%429K75.53%165K140.12%132K115.38%84K
Cash from discontinued financing activities
Financing cash flow 92.82%-66K-146.23%-368K39.60%-241K-109.09%-299K-19.30%1.09M-6,464.29%-919K-97.14%796K-40,000.00%-399K76.17%-143K3,855.56%1.35M
Net cash flow
Beginning cash position -25.53%17.98M-29.21%24.15M-33.43%12.95M-32.97%14.74M-28.73%20.15M-29.21%24.15M71.30%34.11M-48.75%19.45M-43.25%21.99M-32.88%28.27M
Current changes in cash 73.29%-1.07M42.31%-5.84M7.84%5.54M43.57%-1.89M10.64%-5.49M30.64%-4M-169.16%-10.12M236.50%5.14M-318.25%-3.35M-97.15%-6.15M
Effect of exchange rate changes --12K-319.33%-329K-14.09%-510K-88.12%96K163.43%85K--0134.97%150K-432.14%-447K11,442.86%808K47.45%-134K
End cash Position -16.00%16.93M-25.53%17.98M-25.53%17.98M-33.43%12.95M-32.97%14.74M-28.73%20.15M-29.21%24.15M-29.21%24.15M-48.75%19.45M-43.25%21.99M
Free cash from 49.71%-1.55M24.34%-12.81M384.07%1.36M-9.02%-3.49M-1.21%-7.6M46.47%-3.08M-20.98%-16.93M88.78%-477K-794.69%-3.2M-139.50%-7.51M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg